Certara stock.

4 Apr 2023 ... Certara (CERT), a developer of biosimulation software for drug discovery, dropped Tuesday after Barclays downgraded on valuation concerns.

Certara stock. Things To Know About Certara stock.

Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $59,690 on 31 March 2023.3,990 units of CERT stock worth $59,690 on 31 March 2023.Certara Inc. 1699 South Hanley Road. St. Louis, Missouri 63144-2319. Phone 314 647-1099. Industry Software. Sector Technology. Fiscal Year-end N/A. Revenue.Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares. PRINCETON, N.J.— November 7, 2022 — Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and building transformational healthcare companies, has ...When is Certara (NASDAQ:CERT) reporting earnings? A. Certara ( CERT) is scheduled to report earnings on February 28, 2024. The last reported earnings were for reported on November 8, 2023 for Q3. Q.

ETF Watch. Macquarie Introduces Its First U.S. ETFs. Gabe Alpert | Nov 30, 2023. Our CERT ETF report shows the ETFs with the most CERT exposure, the top performing CERT ETFs, and most popular CERT ...

The institutional investor owned 3,910,996 shares of the company's stock after buying an additional 346,460 shares during the quarter. JPMorgan Chase & Co. owned about 2.45% of Certara worth $84,008,000 at the end of the most recent reporting period. A number of other hedge funds have also added to or reduced their stakes in the stock.

Nov 10, 2023 · Certara Inc’s Stock Price as of Market Close. As of November 10, 2023, 4:00 PM, CST, Certara Inc’s stock price was $13.50. Certara Inc is up 6.72% from its previous closing price of $12.65. During the last market session, Certara Inc’s stock traded between $12.61 and $13.36. Currently, there are 159.17 million shares of Certara Inc stock ... The estimated Net Worth of William F Feehery is at least $78.7 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $45,530,211 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Nov 30, 2023 · Stock analysis for Certara Inc (CERT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Josh Xie is Director-Clinical Pharmacology at Certara, Inc. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Stock markets for all 100% Free Registration. 100% Free RegistrationIn connection with the offering, the Selling Stockholders have granted the underwriter a 30-day option to purchase up to 1,050,000 additional shares. No shares are being sold by Certara. The Selling Stockholders will receive all of the proceeds from this offering. The last reported sale price of Certara’s common stock on August 11, 2022 was ...

Nov 24, 2023 · Bank of Montreal Can purchased a new stake in shares of Certara, Inc. (NASDAQ:CERT – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 10,490 shares of the company’s stock, valued at approximately $194,000. A number of other hedge funds and other institutional […]

Find real-time CERT - Certara Inc stock quotes, company profile, news and forecasts from CNN Business.

Certara Inc Stock Price History. Certara Inc’s price is currently up 18.87% so far this month. During the month of November, Certara Inc’s stock price has reached a high of $14.58 and a low of $11.81. Over the last year, Certara Inc has hit prices as high as $24.96 and as low as $11.81. Year to date, Certara Inc’s stock is down 49.01%.PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...As of now, Certara’s stock opened at $18.19 on Friday, with a market cap of $2.91 billion. The company has a price-to-earnings ratio of 202.11 and a price-to-earnings-growth ratio of 0.96, indicating the market’s confidence in its future growth potential. Certara’s beta stands at 1.58, reflecting its sensitivity to market volatility.Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.10 Des 2020 ... (Reuters) -U.S. drug development consultancy Certara Inc said on Thursday it sold shares in its initial public offering at $23 apiece, ...Certara Inc stock performance at a glance. Check Certara Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.

Or log in with. Google TwitterFind the latest TETRA Technologies, Inc. (TTI) stock quote, history, news and other vital information to help you with your stock trading and investing.Certara Stock Performance. Certara stock opened at $14.71 on Tuesday. The stock’s 50 day moving average price is $13.73 and its 200 day moving average price is $16.78. The firm has a market capitalization of $2.35 billion, a PE ratio of -70.05, a price-to-earnings-growth ratio of 1.15 and a beta of 1.51. The company has a debt-to-equity ratio ...While strong estimate revisions for Certara, Inc. have attracted decent investments and pushed the stock 13.2% higher over the past four weeks, further upside may still be left in the stock.Mar 17, 2023 · In terms of valuation, Certara Inc. stock appears to be trading at a premium compared to its peers in the same industry. The company's market capitalization stands at approximately $3.1 billion ... Mar 29, 2021 · PRINCETON, N.J.– March 29, 2021 –Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 11,500,000 shares of its common stock by certain existing stockholders at a public offering price of $25.00 per share. The closing includes 1,500,000 shares sold upon full ...

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.The estimated Net Worth of Richard M. Traynor is at least $10.2 Million dollars as of 6 March 2023. Mr Traynor owns over 10,000 units of Certara stock worth over $4,562,422 and over the last 2 years he sold CERT stock worth over $5,603,360.

Certara Inc Ordinary Shares 700 Morningstar Rating Unlock Stock XBER Rating as of Nov 17, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation...Certara is listed on the Nasdaq stock exchange under the ticker symbol “CERT.” When did Certara go public, and what was the offering price? Certara’s initial public offering was on December 11, 2020 at $23 per share.Complete Certara Inc. stock information by Barron's. View real-time CERT stock price and news, along with industry-best analysis. 5.27 M Change from Last -18.62% Percent of Float 4.84% Research & Ratings Certara Inc. Per-Share Earnings, Actuals and Estimates Actual Analyst Range Consensus More View the latest Certara Inc....Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Certara Inc have a median target of 19.00, with a high estimate of 21.00 and a low estimate of 16.00. The median estimate ... Oct 11, 2023 · PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023. From Nasdaq : Certara, which provides biosimulation software and services used for drug development, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $500 million. The company uses its biosimulation software and technology to ...View the latest Corteva Inc. (CTVA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Nov 21, 2023 · PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ...

Get the latest information on Certara, Inc. (CERT) stock, including its performance, outlook, earnings, dividends, and insider transactions. See how CERT stock compares to other medical AI companies and the healthcare industry.

Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued. ... Certara, Inc. (CERT) NasdaqGS - NasdaqGS Real Time ...

11 Jan 2022 ... Get Certara Inc (CERT.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.A Barchart Premier membership lets you screen on these options using advanced filters, including strategies for Covered Calls, Naked Puts and Option Spreads ...1.53. +0.02. +1.66%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Certara Inc CERT:US Nasdaq GS (USD) Delayed price as of 2:59 PM EST 11/21/23. Market open. 14.45 –0.27 –1.80% Prev. close 14.71 USD 14.45 USD 3:00 PM …Certara (CERT) stock rose ~15% on Thursday after Q4 results beat estimates and the company's FY23 outlook range surpassed analysts expectations.Adjusted EPS grew +166.6% Y/Y to $0.16,...1.37%. $3.03B. META | Complete Meta Platforms Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Oct 11, 2023 · PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023. Shares of Certara, Inc. (NASDAQ:CERT – Get Free Report) have earned an average recommendation of “Hold” from the eight research firms that are currently covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 …Certara, Inc. (NASDAQ:CERT) Market Cap: $2.3B Certara, Inc. (NASDAQ:CERT) offers software products for using bio-simulation in drug discovery, preclinical and clinical research.Mar 24, 2021 · Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (“the selling stockholders”) at a price to the public of $25.00 per share. Additionally, the selling stockholders have granted the ... A Barchart Premier membership lets you screen on these options using advanced filters, including strategies for Covered Calls, Naked Puts and Option Spreads ...As of now, Certara’s stock opened at $18.19 on Friday, with a market cap of $2.91 billion. The company has a price-to-earnings ratio of 202.11 and a price-to-earnings-growth ratio of 0.96, indicating the market’s confidence in its future growth potential. Certara’s beta stands at 1.58, reflecting its sensitivity to market volatility.

PRINCETON, NJ.—. December 3, 2020 – Certara, Inc. (“Certara”) today announced the launch of its initial public offering of 24,390,000 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 14,630,000 shares of common stock and certain selling ...The estimated Net Worth of Richard M. Traynor is at least $8.76 Million dollars as of 11 May 2023. Mr Traynor owns over 5,000 units of Certara stock worth over $2,938,988 and over the last 3 years he sold CERT stock worth over $5,825,760.Insiders trading at Certara. Over the last 4 years, insiders at Certara have traded over $2,047,095,989 worth of Certara stock and bought 97,245 units worth $1,908,085 . The most active insiders traders include Avatar Parent L.P.Eqt Avata..., James E Iii Cashman, and Mason P Slaine.On average, Certara executives and independent …Instagram:https://instagram. lucid truck pricehow to buy shiba inu cryptowhere to buy futuresthree big automakers 1.90%. $360.63M. Adtran Networks SE. 0.50%. €1.02B. CIEN | Complete Ciena Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t... vanguard money market interest ratealternatives to m1 finance 54.33%. Get the latest Certara Inc (CERT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … best shorted stocks Mar 24, 2021 · Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (“the selling stockholders”) at a price to the public of $25.00 per share. Additionally, the selling stockholders have granted the ... Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screens